"Mercer Bucks Cardiology is the leading provider of complete cardiovascular health services, serving patients throughout Mercer County, NJ and Bucks County, PA. Our practice has been providing care to our local communities since 1997."

During the past decade, Mercer Bucks Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercer Bucks Cardiology" #1 sponsor was "Pfizer" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercer Bucks Cardiology" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thoratec Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mercer Bucks Cardiology" are "Cardiovascular Disease" (3 trials), "Heart Failure" (2 trials) and "Heart Failure With Left Bundle Branch Block" (1 trials). Many other conditions were trialed in "Mercer Bucks Cardiology" in a lesser frequency.

Most popular intervention types in "Mercer Bucks Cardiology" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "HM II (HeartMate II LVAD)" (1 trials), "Methotrexate" (1 trials) and "OMM (Optimal Medical Management)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercer Bucks Cardiology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Mercer Bucks Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mercer Bucks Cardiology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mercer Bucks Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".